Wearable Cardioverter-Defibrillator Use in Patients Perceived to Be at High Risk Early Post-Myocardial Infarction
Wearable Cardioverter-Defibrillator Use in Patients Perceived to Be at High Risk Early Post-Myocardial Infarction
复制标题
DOI：
10.1016/j.jacc.2013.05.086
复制
发表时间：
2013-11-19
影响因子：
24
通讯作者：
Szymkiewicz, Steven J.
中科院分区：
文献类型：
--
作者：
Epstein, Andrew E.;Abraham, William T.;Szymkiewicz, Steven J.
目的本研究的目的是描述在心肌梗死（MI）后强制等待期内对被认为具有心脏骤停（SCA）高风险的患者使用可穿戴心律转复除颤器（WCD）的情况。背景当前的设备指南和保险范围要求在心肌梗死（MI）后植入心律转复除颤器之前等待40天或3个月，方法：我们评估了在MI后前3个月内接受WCD治疗的患者的特征和结局。在WCD医嘱登记处检索编码为“近期MI伴射血分数”的患者
Objectives The aim of this study was to describe usage of the wearable cardioverter-defibrillator (WCD) during mandated waiting periods following myocardial infarction (MI) for patients perceived to be at high risk for sudden cardiac arrest (SCA).Background Current device guidelines and insurance coverage require waiting periods of either 40 days or 3 months before implanting a cardioverter-defibrillator post-myocardial infarction (MI), depending on whether or not acute revascularization was undertaken.Methods We assessed characteristics of and outcomes for patients who had a WCD prescribed in the first 3 months post-MI. The WCD medical order registry was searched for patients who were coded as having had a "recent MI with ejection fraction